150 related articles for article (PubMed ID: 8870649)
21. Activation of protein kinase C induces nuclear translocation of RFX1 and down-regulates c-myc via an intron 1 X box in undifferentiated leukemia HL-60 cells.
Chen L; Smith L; Johnson MR; Wang K; Diasio RB; Smith JB
J Biol Chem; 2000 Oct; 275(41):32227-33. PubMed ID: 10918054
[TBL] [Abstract][Full Text] [Related]
22. Bryostatins mimic the effects of phorbol esters in intact human platelets.
Tallant EA; Smith JB; Wallace RW
Biochim Biophys Acta; 1987 Jun; 929(1):40-6. PubMed ID: 3036247
[TBL] [Abstract][Full Text] [Related]
23. Establishment of a murine leukaemia cell line resistant to the growth-inhibitory effect of bryostatin 1.
Prendiville J; McGown AT; Gescher A; Dickson AJ; Courage C; Pettit GR; Crowther D; Fox BW
Br J Cancer; 1994 Oct; 70(4):573-8. PubMed ID: 7917900
[TBL] [Abstract][Full Text] [Related]
24. STAT1 mediates differentiation of chronic lymphocytic leukemia cells in response to Bryostatin 1.
Battle TE; Frank DA
Blood; 2003 Oct; 102(8):3016-24. PubMed ID: 12855573
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of leukemic cell growth by the protein kinase C activator bryostatin 1 correlates with the dephosphorylation of cyclin-dependent kinase 2.
Asiedu C; Biggs J; Lilly M; Kraft AS
Cancer Res; 1995 Sep; 55(17):3716-20. PubMed ID: 7641182
[TBL] [Abstract][Full Text] [Related]
26. Effects of bryostatin 1, a novel anticancer agent, on intestinal transport and barrier function: role of protein kinase C.
Farokhzad OC; Mun EC; Sicklick JK; Smith JA; Matthews JB
Surgery; 1998 Aug; 124(2):380-6; discussion 386-7. PubMed ID: 9706162
[TBL] [Abstract][Full Text] [Related]
27. Effect of phorbol and bryostatin I on chondrogenic expression of chick limb bud, in vitro.
Garrison JC; Pettit GR; Uyeki EM
Life Sci; 1987 Oct; 41(17):2055-61. PubMed ID: 3118121
[TBL] [Abstract][Full Text] [Related]
28. Different biological effects of the two protein kinase C activators bryostatin-1 and TPA on human carcinoma cell lines.
Steube KG; Grunicke D; Drexler HG
Invest New Drugs; 1994; 12(1):15-23. PubMed ID: 7960600
[TBL] [Abstract][Full Text] [Related]
29. Bryostatin 1, an activator of protein kinase C, inhibits tumor promotion by phorbol esters in SENCAR mouse skin.
Hennings H; Blumberg PM; Pettit GR; Herald CL; Shores R; Yuspa SH
Carcinogenesis; 1987 Sep; 8(9):1343-6. PubMed ID: 3621472
[TBL] [Abstract][Full Text] [Related]
30. Expression of proto-oncogene c-jun during differentiation of B-chronic lymphocytic leukemia.
Gignac SM; Buschie M; Pettit GR; Hoffbrand AV; Drexler HG
Leukemia; 1990 Jun; 4(6):441-4. PubMed ID: 2113601
[TBL] [Abstract][Full Text] [Related]
31. Phorbol ester and bryostatin effects on growth and the expression of oestrogen responsive and TGF-beta 1 genes in breast tumour cells.
Nutt JE; Harris AL; Lunec J
Br J Cancer; 1991 Oct; 64(4):671-6. PubMed ID: 1911215
[TBL] [Abstract][Full Text] [Related]
32. Co-induction of lymphokine synthesis by the antineoplastic bryostatins.
Mohr H; Pettit GR; Plessing-Menze A
Immunobiology; 1987 Nov; 175(5):420-30. PubMed ID: 3123367
[TBL] [Abstract][Full Text] [Related]
33. Evidence for protein kinase C--independent pathways mediating phorbol ester induced plasmacytoid differentiation of B chronic lymphocytic leukemia cells.
Murphy JJ; Yaxley JC; Norton JD
Biochim Biophys Acta; 1991 Mar; 1092(1):110-8. PubMed ID: 1706940
[TBL] [Abstract][Full Text] [Related]
34. The effect of bryostatin on protein kinase C-regulated functions in human T lymphocytes and epidermal keratinocytes.
Galron D; Tamir A; Gelkop S; Grossman N; Isakov N
Immunol Lett; 1993 Dec; 39(1):17-22. PubMed ID: 8144186
[TBL] [Abstract][Full Text] [Related]
35. Bryostatin, a non-phorbol macrocyclic lactone, activates intact human polymorphonuclear leukocytes and binds to the phorbol ester receptor.
Berkow RL; Kraft AS
Biochem Biophys Res Commun; 1985 Sep; 131(3):1109-16. PubMed ID: 2996535
[TBL] [Abstract][Full Text] [Related]
36. The effects of protein kinase-C agonists on parathyroid hormone release and intracellular free Ca2+ in bovine parathyroid cells.
Membreño L; Chen TH; Woodley S; Gagucas R; Shoback D
Endocrinology; 1989 Feb; 124(2):789-97. PubMed ID: 2536321
[TBL] [Abstract][Full Text] [Related]
37. Bryostatin 1 antagonizes the terminal differentiating action of 12-O-tetradecanoylphorbol-13-acetate in a human colon cancer cell.
McBain JA; Pettit GR; Mueller GC
Carcinogenesis; 1988 Jan; 9(1):123-9. PubMed ID: 3335036
[TBL] [Abstract][Full Text] [Related]
38. Two protein kinase C activators, bryostatin-1 and phorbol-12-myristate-13-acetate, have different effects on haemopoietic cell proliferation and differentiation.
Ng SB; Guy GR
Cell Signal; 1992 Jul; 4(4):405-16. PubMed ID: 1419483
[TBL] [Abstract][Full Text] [Related]
39. Stimulation of phosphatidylcholine synthesis by activators of protein kinase C is dissociable from increased phospholipid hydrolysis.
Kiss Z; Chattopadhyay J; Pettit GR
Biochem J; 1991 Jan; 273(Pt 1)(Pt 1):189-94. PubMed ID: 1989580
[TBL] [Abstract][Full Text] [Related]
40. Bryostatin and CD40-ligand enhance apoptosis resistance and induce expression of cell survival genes in B-cell chronic lymphocytic leukaemia.
Kitada S; Zapata JM; Andreeff M; Reed JC
Br J Haematol; 1999 Sep; 106(4):995-1004. PubMed ID: 10520003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
